CIK 0001761918
- Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831217027
- Phone
- +1 858-465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-04 | Morris Shannon Chief Medical Officer | Exercise or conversion 10b5-1 | +20,000 | $1.70 | $34K | 20,000 |
| 2026-03-04 | Morris Shannon Chief Medical Officer | Sale 10b5-1 | −20,000 | $15.04 | $301K | 0 |
| 2026-01-29 | Morris Shannon Chief Medical Officer | Grant or award · Stock option (right to buy) | +625,000 | 625,000 | ||
| 2025-03-04 | Morris Shannon Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −20,000 | 515,800 | ||
| 2025-02-03 | Morris Shannon Chief Medical Officer | Grant or award · Stock option (right to buy) | +780,000 | 780,000 | ||
| 2024-06-20 | Morris Shannon Chief Medical Officer | Grant or award · Stock Option (right to buy) | +137,142 | 137,142 | ||
| 2024-02-05 | Morris Shannon Chief Medical Officer | Grant or award · Stock Option (right to buy) | +535,800 | 535,800 | ||
| 2023-04-10 | Morris Shannon Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 |
Page 1 of 1 · 8 trades